Role of Somatostatin Analogues in the Treatment of Neuroendocrine Tumors

Journal of the National Comprehensive Cancer Network : JNCCN - United States
doi 10.6004/jnccn.2015.0012
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Harborside Press, LLC

Related search

Somatostatin Receptor Endoradiotherapy of Neuroendocrine Tumors: Experience in Hungarian Patients

Orvosi Hetilap
Medicine
2011English

Somatostatin Analogue Treatment of Neuroendocrine Tumours.

Postgraduate Medical Journal
Medicine
1996English

Peptide Receptor Radionuclide Therapy Plus Somatostatin Analogues for a Neuroendocrine Tumour Combined and Maintenance Treatment

Clinical and Translational Imaging
Nuclear MedicineRadiologyImaging
2019English

Cost-Effectiveness of Somatostatin Analogues for the Treatment of Acromegaly in Colombia

Open Journal of Endocrine and Metabolic Diseases
2012English

Medical Treatment With Somatostatin Analogues in Acromegaly: Position Statement

The Korean Journal of Medicine
2019English

Prognostic Significance of AKT/mTOR Signaling in Advanced Neuroendocrine Tumors Treated With Somatostatin Analogs

OncoTargets and Therapy
OncologyPharmacology
2012English

Treatment Patterns of Gastrointestinal Neuroendocrine Tumors (NET).

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2017English

Multiple Effects of Somatostatin Analogs Verified in Three Cases of Metastasized Neuroendocrine Tumors of the Gastroenteropancreatic System

Tumori
MedicineCancer ResearchOncology
2006English

Role of Sunitinib for the Management of Pancreatic Neuroendocrine Tumors

Gastrointestinal Cancer: Targets and Therapy
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy